Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Young patients with knee disorder get active after new Stanford surgical procedure

Young patients with knee disorder get active after new Stanford surgical procedure

April 01, 2008

STANFORD, Calif. - At 14 years old, Adam Vasser of Los Altos, Calif., was an active kid who loved baseball. Then a mysterious virus attacked his heart, making a heart transplant necessary to save his life.

He underwent long-term steroid treatment to prevent transplant rejection, which left him with an excruciating knee disorder called osteonecrosis. Now 23 and nearing graduation from college, after enduring 15 surgeries for his knee and heart, he's finally been able to return to sports.




Thanks to a new surgical technique used on Vasser's left knee called "cellular grafting," the 23-year-old is out cycling and refereeing soccer games on a virtually pain-free knee. The procedure was done for the first time on three young patients with steroid-induced osteonecrosis of the knee by orthopedic surgeon Stuart Goodman, MD, PhD, and is described in a preliminary report to be published in the April issue of the Journal of Arthroplasty.

"Even though a knee sounds like a little thing after all Adam's been through, it was big to get it fixed," said Adam's mother, Karen Vasser of Los Altos, who took her son from one doctor to another looking for help. "He was real athletic so the knee was one of the things that prevented him from getting back."

The new surgical technique involves transplanting cellular material from the pelvic area into the knee. Two years after surgery, Goodman said, all three patients had returned to nearly normal activity and knee function with no complications.

"It's a fairly simple procedure," said Goodman, the Robert L. and Mary Ellenburg Professor in Surgery at the Stanford University School of Medicine.

Osteonecrosis of the knee is a rare disorder. When it occurs in young people, it's most often the result of steroid therapy and is called secondary osteonecrosis. The bones in the knee start to die from a loss of blood supply, leading to severe pain, progressive arthritis and eventually the need for artificial joint replacement.

"Many patients do OK without surgical treatment," Goodman said. "With those patients, I wait and prescribe pain medication." But for young patients who still have a lifetime of activity ahead of them, Goodman wanted alternatives.

When Vasser first started looking for knee treatments, he was told by several doctors to simply use crutches until the knee collapsed and then get an artificial knee replacement. Pain medication was discouraged because of its effects on his kidneys after all the heart transplant treatment drugs. He, too, was searching for a better answer when he met Goodman.

All three of Goodman's patients were between the ages of 18 and 21 and suffering from steroid-induced osteonecrosis. Among the two other patients, one had a diagnosis of Crohn's disease and the other had been treated with high-dose steroids for severe optic nerve swelling associated with the use of minocycline.

The 60-minute surgery, called osteoprogenitor cellular grafting, involves scooping out the dead bone and then filling the space in with new cellular matter.

"The key is to arrest or reverse the death of the bone," Goodman said. "If the cartilage is good, you get the dead bone out and give the cartilage a better foundation. If you have a salvageable joint in a young knee, you get in viable cells to repopulate that area of dead bone."

Goodman theorized that instead of using traditional bone grafting - a more invasive and painful solution - a better method might be using bone cells. The bone cells include young stem cells and progenitor cells that can actually grow into new bone. He withdrew bone marrow from the pelvic area, concentrated the stem cells and progenitors, then used a scaffolding device to help the cells adhere to the defect in the knee.

Based on the success of these three surgeries, Goodman recommends a longer-term follow-up study with a larger number of patients.

Vasser underwent the knee surgery the summer after he graduated from high school. He described a painful, monthlong recuperation period, but said that since then his knee has improved to be almost like new five years later. His mother showed a photo of him crouching behind the home plate, playing umpire in a baseball game the year following surgery.

"My knee has felt good ever since," Vasser said. "It's much stronger than it used to be. It used to lock up. Towards the end before the surgery, it got really bad. I'm refereeing, riding a bike. It doesn't affect it. It's fine."

Stanford University Medical Center



Related Osteonecrosis Current Events and Osteonecrosis News Articles Osteonecrosis Current Events and Osteonecrosis News RSS Osteonecrosis Current Events and Osteonecrosis News RSS
Treating osteoporosis calls for physician, dentist collaboration: ADA Journal
Physicians and dentists should collaborate to improve early detection and treatment of patients who have or may develop osteoporosis, say researchers in the cover story of the May issue of The Journal of the American Dental Association.

USC School of Dentistry researchers uncover link between osteoporosis drugs and jaw infection
A group of University of Southern California School of Dentistry researchers says it has identified the slimy culprits killing the jawbones of some people taking drugs that treat osteoporosis.

Popular osteoporosis drugs triple risk of bone necrosis
A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain.

Bisphosphonate treatment is associated with jaw bone problems
Patients treated with intravenous bisphosphonates are at an increased risk of jaw or facial bone deterioration or infection.

Down in the mouth?
A woman's mouth has a lot to say, even when it's not talking. Things that alter the female body, such as prescription medications to help prevent diseases such as osteoporosis or depression, diabetes, or a vitamin deficiency, can affect a woman's oral health.

New method predicts hip joint decay from chemotherapy
Investigators at St. Jude Children's Research Hospital say they have found the best way for predicting when patients will need future surgery to repair hip joints that have deteriorated because of pediatric leukemia or lymphoma treatment.

Drug used for advanced cancer could cause exposed bone in jaw
A type of drug used to strengthen bones when cancer has spread there may be linked to a side effect that involves deterioration of the jaw bone, according to two new reviews of cancer literature.

Mayo Clinic: New recommendations for use of bisphosphonates in treatment of multiple myeloma
Mayo Clinic's multiple myeloma (MM) research team has jointly issued a consensus statement regarding the use of bisphosphonates to prevent or treat bone disease in MM.

Oral bisphosphonate risk slight, but dental patients should be aware, ADA says
People taking oral bisphosphonates, a type of drug used to treat osteoporosis, osteopenia and Paget's disease of bone, should be aware of potential risks when undergoing certain dental procedures.
More Osteonecrosis Current Events and Osteonecrosis News Articles
Osteonecrosis (Clinical Orthopaedics & Related Research, Vol 130)



Osteonecrosis - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
by ICON Health Publications

In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and...



Osteonecrosis: Etiology, Diagnosis, and Treatment

Comprehensive text on the subject of osteonecrosis of the human skeleton. Based on a symposium entitled: Osteonecrosis: Etiology, Diagnosis, and Management, held at Duke University, Durham, NC, on November 6-9, 1996. Halftone illustrations. DNLM:...



21st Century Complete Medical Guide to Osteonecrosis, Avascular Necrosis, Kienbock¿s Disease, Legg-Calve-Perthes Disease, Authoritative Government Documents, Clinical References, and Practical Information for Patients and Physicians (CD-ROM)
by PM Medical Health News

This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of osteonecrosis and related disorders. This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is provided in clearly written...



Oral & Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws: History, Etiology, Prevention, and Treatment
by Robert E. Marx

Since it was first identified in 2003, bisphosphonate-induced osteonecrosis has come under growing scrutiny by medical and dental specialists alike because it affects cancer patients receiving intravenous bisphosphonate therapy and osteoporosis patients receiving oral bisphosphonate therapy and yet its presentation of exposed bone is limited to the jaws. Based on a clear understanding of the...

Jaw osteonecrosis tied to infusion exposure.(Clinical Rounds): An article from: Family Practice News
by Kerri Wachter

This digital document is an article from Family Practice News, published by Thomson Gale on July 15, 2007. The length of the article is 764 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Jaw...

Bisphosphonates and Osteonecrosis of the Jaw (Annals of the New York Academy of Sciences)
by John P. Bilezikian, John T. Grbic, G. David Roodman

Not an evidence-based approach: consider adjunctive medications in osteonecrosis.(Clinical Rounds): An article from: Internal Medicine News
by Bruce Jancin

This digital document is an article from Internal Medicine News, published by International Medical News Group on April 15, 2004. The length of the article is 648 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Osteonecrosis in 1% of IV bisphosphonate users.(Metabolic Disorders): An article from: Family Practice News
by Sharon Worcester

This digital document is an article from Family Practice News, published by Thomson Gale on September 1, 2006. The length of the article is 706 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...

Is your osteoporosis medication killing your jaw? Research links bisphosphonates to rare, but serious, jaw osteonecrosis; prevention seen as best "cure.".(BONES & JOINTS): An article from: Health News
by Thomas Weber

This digital document is an article from Health News, published by Thomson Gale on December 1, 2006. The length of the article is 917 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Is your...

© 2008 BrightSurf.com